¸²ÇÁÁ¾ÀÇ Áø´ÜÀº ±âº»ÀûÀ¸·Î Ä¿Áø ¸²ÇÁÀýÀÇ Á¶Á÷°Ë»ç¸¦ ÅëÇØ º´¸®¼Ò°ßÀ» º¸°í Áø´ÜÀ» ÇÏ°Ô µË´Ï´Ù. º´¸®¼Ò°ßÀ» Åä´ë·Î È£ÁîŲº´°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾Àº °¢°¢ ¾Æ·¡Ç¥¿Í °°ÀÌ ºÐ·ùÇÒ ¼ö ÀÖ½À´Ï´Ù.
º´±â°áÁ¤À» À§ÇÑ °Ë»çµé·Î´Â ÀϹÝÇ÷¾×°Ë»ç(CBC), Ç÷û³» °£±â´É°Ë»ç ¹× ½Å±â´É°Ë»ç, Ç÷û LDH ¹× ¿ä»êÄ¡, ÈäºÎX-¼± ¹× Àü»êÈ´ÜÃþÃÔ¿µ(CT), º¹ºÎ ÃÊÀ½ÆÄ ¹× Àü»êÈ´ÜÃþÃÔ¿µ(CT), °ñ½ºÄµ PET/CT ¹× °ñ¼öõÀÚ ¹× »ý°Ë, ³úô¼ö¾×°Ë»ç µîÀÌ ÀÖ½À´Ï´Ù.
ºñÈ£ÁöŲ ¸²ÇÁÁ¾ÀÇ ºÐ·ùo Burkitt lymphoma ¹öŶ ¸®ÇÁÁ¾¡¤ t(8;14) (90%) ¡¤ t(2;8) ¶Ç´Â t(8;22) (10%) o Diffuse large B-cell lymphoma ¹Ì¸¸¼º ´ë¼¼Æ÷ B-¼¼Æ÷Çü ¸²ÇÁÁ¾o Lymphoblastic lymphoma ¸²ÇÁ¾Æ¼¼Æ÷ o Anaplastic large cell lymphoma ¹ÌºÐÈ ´ë¼¼Æ÷ ¸²ÇÁÁ¾ ¡¤ T¼¼Æ÷Çü (70%) ¡¤ B ¼¼Æ÷Çü (10%) ¡¤ Null ¼¼Æ÷Çü (20%) ¡¤ t(2;5) µ¿¹Ý (90%)